This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.

A pioneer in value investing, Gabelli Funds (www.gabelli.com) is credited with developing the Private Market Value with a Catalyst™ stock selection process. Since launching our flagship Gabelli Asset Fund (GABAX) in 1986, we have evolved into a diversified global financial services company offering an extensive range of investment capabilities. Fundamental bottoms-up research combined with long-term accumulated knowledge of sectors and companies has been key to our success. For more real time portfolio insights & stock ideas subscribe to GabelliTV on YouTube. Social Media: Twitter, LinkedIn, Instagram, Facebook

Gabelli Funds

January 11, 2021

Charged Up

Growth in EVs and the charging infrastructure will require considerable coordination among major stakeholders, including the automotive Original Equipment Manufacturers (OEMs), utilities, charging station manufacturers, municipalities and governments.

Read More
Gabelli Funds

December 21, 2020

Vertical Farming

A vertical farm replicates the traditional growing conditions of a farm – light, air, water, nutrients, and support/growing media – but does so with artificial substitutes in order to deliver higher yields and faster crop production.

Read More
Gabelli Funds

October 12, 2020

Demystifying SaaS Unit Economics

Investors are increasingly using LTV/CAC and other metrics (sales efficiency, payback period, R&D efficiency) to justify the sky-high multiples seen across SaaS.

Read More
Gabelli Funds

June 22, 2020

A Day of Next-Generation Sequencing: Leerink Annual Next Gen Sequencing Day

On June 8th, 2020, Leerink virtually hosted its annual Next-Gen Sequencing (NGS) Day. Various companies participated in a fireside chat format, including NeoGenomics, Invitae, Illumina, and Natera. We summarize the key takeaways from the day, highlighting how NGS will be an integral part of future diagnostics advancements.

Read More
Gabelli Funds

June 1, 2020

Company Update: SmileDirectClub, Inc.

We compare SmileDirectClub’s clear aligner product offering vis-à-vis Align Technology’s product offering. Align has noted SDC’s model does not compete directly as Align goes through its doctor base for all its products.

Read More
Gabelli Funds

April 27, 2020

Business & Testing Update: Abbott Laboratories

Abbott Labs on target to ship 5 million tests in April, ramping up to 26 million tests in June. Abbott Laboratories has launched three diagnostic tests for coronavirus since March 18, 2020. The company is on target to ship 5 million tests in April, ramping up to 26 million tests in June.

Read More
Gabelli Funds

April 13, 2020

Stress Testing Utility Dividend Policies

Currently, dividends as percent of 2020 EPS are reasonably low at 61%, and short-term impacts associated with commercial and industrial sales and bad debt/un-collectibles are recoverable through the regulatory process.

Read More
trading top